MediWound Ltd.
MDWD
$17.10
$0.814.97%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | 20.63% | 20.63% | -339.74% | ||
| Total Depreciation and Amortization | 2.06% | 2.06% | 7.62% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -154.97% | -154.97% | 81.35% | ||
| Change in Net Operating Assets | 278.48% | 278.48% | 71.60% | ||
| Cash from Operations | 19.56% | 19.56% | 38.09% | ||
| Capital Expenditure | -31.10% | -31.10% | -58.22% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 274.68% | 274.68% | 83.44% | ||
| Cash from Investing | 186.27% | 186.27% | 77.65% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 15.00% | 15.00% | -52.87% | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 100.00% | 100.00% | -96.37% | ||
| Cash from Financing | 71.94% | 71.94% | -79.51% | ||
| Foreign Exchange rate Adjustments | 566.67% | 566.67% | 32.50% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 126.17% | 126.17% | 68.96% | ||